Stock SUDARSHAN SUDARSHAN PHARMA INDUSTRIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Sudarshan Pharma Industries Limited

Equities

SUDARSHAN

INE00TV01015

Market Closed - Bombay S.E.
Other stock markets
 11:00:51 17/05/2024 BST 		5-day change 1st Jan Change
69 INR +5.23% Intraday chart for Sudarshan Pharma Industries Limited -1.32% -15.12%
04-01 Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer CI
03-30 1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer
CI
1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
11,224,937 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
CI
Sudarshan Pharma Industries Limited Appoints Sachin Mehta as the Chief Financial Officer, Effective December 12, 2023
CI
Sudarshan Pharma Industries Limited Announces Resignation of Nilesh Thakkar as Additional Director
CI
Sudarshan Pharma Industries Limited Announces Board Changes
CI
Sudarshan Pharma Industries Limited Announces Resignation of Mr. Dharam Jilka from the Position of Chief Financial Officer with Effect from September 15, 2023
CI
Sudarshan Industries Limited Announces Intimation for Incorporation of A Subsidiary Company
CI
Sudarshan Pharma Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Sudarshan Pharma Industries Limited signed a definitive agreement to acquire Ratna Lifesciences Pvt Ltd for INR 55 million.
CI
Sudarshan Pharma Industries to Consider Acquisition of Ratna Lifesciences as Unit
CI
Sudarshan Pharma Industries Limited Recommends Dividend for the Financial Year 2022-23, Payable on and from September 05, 2023
CI
Sudarshan Pharma Industries Limited Appoints Mr. Rushabh P Patil as Additional Director
CI
Sudarshan Pharma Industries Limited Announces Resignation of RAJESH CHANDRAKUMAR HEDAOO as Director
CI
Sudarshan Pharma Industries Limited has completed an IPO in the amount of INR 501.072 million.
CI
Sudarshan Pharma Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Sudarshan Pharma Industries Limited has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SUDARSHAN Stock
  4. News Sudarshan Pharma Industries Limited